Similar Search Results

State Pharmaceutical Importation Programs : An Analysis of the Cost Effectiveness

Acri née Lybecker, Kristina M.L. - 2019

West Virginia aims to reduce spending on pharmaceuticals by importing them from Canada. To examine the cost effectiveness …

Persistent link: https://www.econbiz.de/10012868596

Impact of parallel trade on pharmaceutical firm’s profits : rise or fall?

Hu, Bin - 2019

the pharmaceutical industry is the presence of price regulation in most countries. Taking into account the impact of …

Persistent link: https://www.econbiz.de/10012871310

Pharmaceutical Opioid Marketing and Physician Prescribing Behavior

Beilfuss, Svetlana - 2019

Physicians' relationships with the pharmaceutical industry have recently come under public scrutiny, particularly in the context of opioid drug prescribing. This study examines the effect of doctor-industry marketing interactions on subsequent prescribing patterns of opioids using linked...

Persistent link: https://www.econbiz.de/10012871515

Externalities of National Pharmaceutical Policy when Markets are Integrated through Parallel Trade

Birg, Laura - 2017

This paper studies externalities of nationally determined cost-sharing systems, in particular coinsurance rates (patients pay a percentage of the price), under pharmaceutical parallel trade in a two-country model with a vertical distributor relationship. Parallel trade generates a...

Persistent link: https://www.econbiz.de/10012973688

Free Movement and Competition in the European Market for Pharmaceuticals

Caro de Sousa, Pedro - 2016

competition in the drug market over time are all shaped by regulation. Throughout much of the world, administrative regulation …Very few industries are as profoundly influenced by regulation as the pharmaceutical industry. All aspects of the life … law in this sphere across the world are concerned with practices that seek to take advantage of or manipulate the …

Persistent link: https://www.econbiz.de/10012980141

Ask Your Doctor or Pharmacist! On the Effect of Self-Dispensing Physicians on Pharmaceutical Coverage

Bannert, Matthias - 2015

In most developed countries drugs are dispensed to patients through physicians and pharmacists. This paper studies the effects of allowing doctors to directly dispense drugs to patients (self-dispensation) on pharmaceutical coverage. We use a Swiss dataset in our empirical analysis because...

Persistent link: https://www.econbiz.de/10013021080

Launch Decisions of Pharmaceutical Companies

Civan, Abdulkadir - 2016

This paper models the launch decision of pharmaceutical companies in regard to new drugs and country markets. New drugs are launched with a delay or not launched at all in many countries. Considering that many of these new drugs would have created health benefits to the patients, there seems to...

Persistent link: https://www.econbiz.de/10012993196

Risky Business : Should the FDA Pay Attention to Drug Prices?

Hyman, David A. - 2018

The Food and Drug Administration currently does not monitor drug prices. As FDA leaders note, the agency's responsibility is for drug safety and efficacy, and besides they do not want to become embroiled in drug pricing controversies. However, monitoring drug pricing can be useful beyond any...

Persistent link: https://www.econbiz.de/10012923980

Conflicts of Interest on Expert Committees : The Case of FDA Drug Advisory Committees

Cooper, James C. - 2018

Governments and firms often use committees of experts to help them make complexdecisions, but conflicts of interest could bias experts' recommendations. We focus on whetherfinancial ties to drug companies bias FDA drug advisory committee (AC) members' voting ondrug approval recommendations. We...

Persistent link: https://www.econbiz.de/10012934325

Hybrid Risk Adjustment for Pharmaceutical Benefits

Garcia-Goñi, Manuel - 2014

This paper analyses the application of hybrid risk adjustment versus either prospective or concurrent risk adjustment formulae in the context of funding pharmaceutical benefits for the population of an integrated healthcare delivery organization in Catalonia during years 2002 and 2003. We apply...

Persistent link: https://www.econbiz.de/10012708365